Replicel

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • JJJJrS
    Senior Member
    • Apr 2012
    • 638

    Originally posted by ccmethinning
    If it worked well, would they really need to retract all the "billion dollar cure" and similar headlines? No, they wouldn't, because if it worked well it in all liklihood would be a "billion dollar cure." I think Iron_Man even conceded that it might show some results in the form of thin vellus hairs. But the results have to be very underwhelming (not nonexistent) to go out of their way and retract those statements.
    Doesn't look good at all.

    I'd love to see Replicel succeed just as much as anybody else here but all signs seem to be indicating otherwise. Whether it's the unnecessary and shameless paid promotions, waiting until the very last possible moment to release results, not mentioning anything about efficacy in the annual report, and now finally this retraction. I think I've lost hope in them now.

    I really hope I get proven wrong and on Monday they show pictures with obvious regrowth/increased hair count, but at the moment, I'm very, very skeptical.

    Comment

    • ccmethinning
      Senior Member
      • Jan 2012
      • 317

      Originally posted by lpenergy
      This is going to be interesting to watch on Monday. They opted to not include any mention of the results in their annual report. I am hoping that their lawyers stepped in and told them to issue the statement to be on the safeside. The only problem is why didn't the lawyers step in and do this earlier if they felt like certain publications were overly optimistic.

      The NBT piece said they expected the stock to be $5.25 in early May. Well, maybe with the results they have in hand, there is no way the stock price is going to get there.
      The timing is way too good to just be lawyers being precautionary. Results are widely believed to be released Monday. For the last 2 weeks they promote the crap out of their stock for $338,000. Since then, the share price has risen almost $1. Now, afterhours on the Friday before the Monday they are presumed to release the results, after the price has been inflated, they now decide to cover their ass with some legal lingo. The damage has been done, hundreds, maybe thousands, of retail investors have been sucked in. Now they are going to drop the bomb on Monday, and be completely free of wrongdoing because they have "retracted" the statements.

      Comment

      • NeedHairASAP
        Senior Member
        • Jul 2011
        • 1408

        Originally posted by 2020
        this announcement was probably made just to avoid legal troubles....

        anyways, I refuse to believe that after a decade of work Replicel will fail completely. Even that paper that "Iron Man" keep showing us only claims that they probably won't be able to grow BRAND NEW FOLLICLES.... there is still hope for diffuse thinners and low norwoods. Half the participants in Replicel's study are women so we'll see how they respond...

        sorry for your loss 2020....

        Comment

        • hairysituation
          Senior Member
          • Feb 2012
          • 206

          Originally posted by ccmethinning
          The timing is way too good to just be lawyers being precautionary. Results are widely believed to be released Monday. For the last 2 weeks they promote the crap out of their stock for $338,000. Since then, the share price has risen almost $1. Now, afterhours on the Friday before the Monday they are presumed to release the results, after the price has been inflated, they now decide to cover their ass with some legal lingo. The damage has been done, hundreds, maybe thousands, of retail investors have been sucked in. Now they are going to drop the bomb on Monday, and be completely free of wrongdoing because they have "retracted" the statements.
          I agree that it sound suspisous, but let us all do ourselves a favour and wait until the trial release. If the results are bad, I will be excited over Iron Man's knowledge. But let's wait and see, and stop speculating.

          Comment

          • Kirby_
            Senior Member
            • Jan 2012
            • 439

            Originally posted by ccmethinning
            http://www.stockhouse.com/News/USRel...aspx?n=8493113

            Use that link. All these stock promoters come out with this lofty language, the stock price runs up, now, just days before release they say "may cause investors to lose their entire investment in the Company."
            Uh oh. They're ****ed. Another Intercytex...

            Comment

            • lpenergy
              Member
              • Mar 2012
              • 60

              Did anyone review the Financial Statements?

              I took a quick pass at the MD&A while I was at work, but there were a couple of things that I picked up on.

              It seems that they have modified the Efficacy Endpoint testing for phase IIa testing. In their MD&A report for 9/30/2011, they indicated that they would test for efficacy at 6 months as a secondary endpoint and release the results in spring of 2012. They would continue testing the patients at 12 month and 24 month endpoints for safety.

              In the most recent MD&A, they have stated that "Analysis of efficacy will also be studied at 9, 12 and 24 months."

              This is new and different. A 9th month efficacy testing to my knowledge has never been discussed previously. So, are they telegraphing that after 6 months time, results may not have been sufficient and so they want to continue to test for efficacy at these additional endpoints?
              Last edited by lpenergy; 04-27-2012, 08:09 PM. Reason: Alcohol impairing my writing skills at the moment

              Comment

              • lpenergy
                Member
                • Mar 2012
                • 60

                Other items noted:

                For those of you who haven't reviewed their report, it can be found at:




                1) They say they "we continue to perform pre‐clinical
                research to improve the production and delivery of our product." This will be a question for an interview as to why this is necessary.

                2) They have included language that broadens their horizons so to speak beyond hair. Under Intellectual Property, it now says "We are
                developing a diverse portfolio of intellectual property for the use of stem cells in the treatment of hair loss, as well as other medical conditions." Later it says, "and the growth and use of these stem cells for the treatment of a variety of medical conditions (including hair loss)." In my opion, this also does not bode well for Monday.

                Comment

                • PvH
                  Member
                  • Jan 2012
                  • 61

                  Originally posted by NeedHairASAP
                  sorry for your loss 2020....
                  thats funny haha

                  Originally posted by Kirby_
                  Uh oh. They're ****ed. Another Intercytex...
                  fool me once.. ahh **** it

                  Comment

                  • WashedOut
                    Senior Member
                    • Dec 2011
                    • 111

                    I don't see why they would go on with phase II if their results are that bad. If they won't get funding then they might as well shut it down now but they must have something that they think investors will see as worth pursuing at the least. This is covering your ass from lawsuits because there is no guarantee the price will go up to a certain amount regardless of the results.

                    Comment

                    • NeedHairASAP
                      Senior Member
                      • Jul 2011
                      • 1408

                      Originally posted by lpenergy
                      This is new and different. A 9th month efficacy testing to my knowledge has never been discussed previously. So, are they telegraphing that after 6 months time, results may not have been sufficient and so they want to continue to test for efficacy at these additional endpoints?


                      I think, sufficient or not, they would be interested in the specific time series (6,9, etc) data sets you mention

                      Comment

                      • Pate
                        Senior Member
                        • Sep 2011
                        • 417

                        Originally posted by lpenergy
                        They say they "we continue to perform pre‐clinical
                        research to improve the production and delivery of our product." This will be a question for an interview as to why this is necessary.
                        Because clinical trials are time consuming, expensive, and subject to strict controls and regulation. If you want to fiddle with the formula or test something new, it's easier, quicker, cheaper and safer to do it in pre-clinical work.

                        Originally posted by lpenergy
                        2) They have included language that broadens their horizons so to speak beyond hair. Under Intellectual Property, it now says "We are developing a diverse portfolio of intellectual property for the use of stem cells in the treatment of hair loss, as well as other medical conditions." Later it says, "and the growth and use of these stem cells for the treatment of a variety of medical conditions (including hair loss)." In my opion, this also does not bode well for Monday.
                        Maybe. Maybe not. I honestly don't know why everybody's getting so worked up because we simply DO NOT KNOW at this stage.

                        The retraction could be something as simple as someone alerted the regulatory authorities and the authorities had words with Replicel. Happens all the time. And to be honest, those stock 'research' reports were laughable and dishonest and this retraction has been a long time coming.

                        It could also be that they have seen no sign of regrowth whatsoever and are facing an imminent disaster of funding that will probably put the company out of business. Hard to see how they could raise funds after that. If there are no results, the best this company can hope for is to be bought out by Aderans IMO.

                        But nobody here knows which it is, or indeed if it's something completely different. So there's no point everybody getting worked up until the results are released. Read the results and THEN bitch and moan, if that's what you wanna do.

                        Comment

                        • Mojo Risin
                          Senior Member
                          • Mar 2011
                          • 157

                          I'm starting to believe there won't be a cure in my lifetime (I'm in my 20s).

                          I'll have to change my avatar of Troll Cotsarelis for Troll David Hall.

                          Comment

                          • lpenergy
                            Member
                            • Mar 2012
                            • 60

                            Okay, if they don't release the results over the weekend (and they probably won't), they will be released either Monday morning prior to the market open or after the market closes. Based upon the retraction, the stock could sell off heavily first thing in the morning.

                            If the results are actually decent, they have a moral obligation to release it over the weekend or in the morning pre-open, otherwise the shares could plummet in the AM, and then shoot back up again Tuesday. In order to avoid this, Replicel should disclose results pre-open. This would cut down on needless volatility.

                            Comment

                            • ccmethinning
                              Senior Member
                              • Jan 2012
                              • 317

                              Originally posted by lpenergy
                              Okay, if they don't release the results over the weekend (and they probably won't), they will be released either Monday morning prior to the market open or after the market closes. Based upon the retraction, the stock could sell off heavily first thing in the morning.

                              If the results are actually decent, they have a moral obligation to release it over the weekend or in the morning pre-open, otherwise the shares could plummet in the AM, and then shoot back up again Tuesday. In order to avoid this, Replicel should disclose results pre-open. This would cut down on needless volatility.
                              I agree. I smell a class action lawsuit if they **** this up more than they already have so far.

                              Comment

                              • VictimOfDHT
                                Senior Member
                                • Apr 2011
                                • 747

                                Originally posted by Mojo Risin
                                I'm starting to believe there won't be a cure in my lifetime (I'm in my 20s).

                                I'll have to change my avatar of Troll Cotsarelis for Troll David Hall.
                                Of course there will....Give it another 5-10 years. And if there isnt a cure by then, just give it another 5-10. But just in case there still isnt one, just give it another 5-10 years..................

                                Comment

                                Working...